Summit Therapeutics Inc
SMMT20.950USD
+0.690+3.41%
收盤 09/26, 16:00（美東）報價延遲15分鐘
15.56B總市值
虧損本益比TTM
關於 公司
公司簡介
公司代碼SMMT
公司名稱Summit Therapeutics Inc
上市日期Oct 14, 2004
CEODr. Mahkam (Maky) Zanganeh
員工數量159
證券類型Ordinary Share
年結日Oct 14
公司地址601 Brickell Key Drive
城市MIAMI
上市交易所NASDAQ Global Market Consolidated
國家United States of America
郵編33131
電話13052032034
網址https://www.smmttx.com/
公司代碼SMMT
上市日期Oct 14, 2004
CEODr. Mahkam (Maky) Zanganeh
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Robert William (Bob) Duggan
Mr. Robert William (Bob) Duggan
Executive Chairman of the Board, Co-Chief Executive Officer
Executive Chairman of the Board, Co-Chief Executive Officer
556.09M
+0.06%
Dr. Mahkam (Maky) Zanganeh
Dr. Mahkam (Maky) Zanganeh
President, Co-Chief Executive Officer, Director
President, Co-Chief Executive Officer, Director
35.74M
+1.02%
Dr. Yu (Michelle) Xia
Dr. Yu (Michelle) Xia
Non-Executive Director
Non-Executive Director
31.52M
--
Mr. Manmeet S. Soni, CPA
Mr. Manmeet S. Soni, CPA
Chief Financial Officer, Chief Operating Officer, Director
Chief Financial Officer, Chief Operating Officer, Director
--
--
Mr. Robert Lacaze
Mr. Robert Lacaze
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Kenneth A. Clark, J.D.
Mr. Kenneth A. Clark, J.D.
Lead Non-Executive Independent Director
Lead Non-Executive Independent Director
--
--
Dr. Alessandra Cesano, M.D., Ph.D.
Dr. Alessandra Cesano, M.D., Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Robert F. Booth, Ph.D.
Dr. Robert F. Booth, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Mostafa Ronaghi, Ph.D.
Dr. Mostafa Ronaghi, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Jeffrey (Jeff) Huber
Mr. Jeffrey (Jeff) Huber
Non-Executive Independent Director
Non-Executive Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Robert William (Bob) Duggan
Mr. Robert William (Bob) Duggan
Executive Chairman of the Board, Co-Chief Executive Officer
Executive Chairman of the Board, Co-Chief Executive Officer
556.09M
+0.06%
Dr. Mahkam (Maky) Zanganeh
Dr. Mahkam (Maky) Zanganeh
President, Co-Chief Executive Officer, Director
President, Co-Chief Executive Officer, Director
35.74M
+1.02%
Dr. Yu (Michelle) Xia
Dr. Yu (Michelle) Xia
Non-Executive Director
Non-Executive Director
31.52M
--
Mr. Manmeet S. Soni, CPA
Mr. Manmeet S. Soni, CPA
Chief Financial Officer, Chief Operating Officer, Director
Chief Financial Officer, Chief Operating Officer, Director
--
--
Mr. Robert Lacaze
Mr. Robert Lacaze
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Kenneth A. Clark, J.D.
Mr. Kenneth A. Clark, J.D.
Lead Non-Executive Independent Director
Lead Non-Executive Independent Director
--
--
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
暫無數據
地區USD
名稱
營收
佔比
Latin America
0.00
0.00%
業務
地區
暫無數據
股東統計
更新時間: 8月23日 週六
更新時間: 8月23日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Duggan (Robert William)
74.86%
Zanganeh (Mahkam)
4.81%
Baker Bros. Advisors LP
4.54%
Xia (Yu)
4.24%
Fidelity Management & Research Company LLC
1.24%
其他
10.30%
持股股東
持股股東
佔比
Duggan (Robert William)
74.86%
Zanganeh (Mahkam)
4.81%
Baker Bros. Advisors LP
4.54%
Xia (Yu)
4.24%
Fidelity Management & Research Company LLC
1.24%
其他
10.30%
股東類型
持股股東
佔比
Individual Investor
84.35%
Investment Advisor
5.54%
Hedge Fund
5.14%
Investment Advisor/Hedge Fund
2.32%
Research Firm
0.25%
Sovereign Wealth Fund
0.19%
Pension Fund
0.07%
Bank and Trust
0.06%
其他
2.09%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
447
727.40M
97.94%
-484.11K
2025Q1
437
723.14M
98.66%
+648.97K
2024Q4
388
717.73M
97.33%
+5.42M
2024Q3
325
708.90M
96.17%
+11.45M
2024Q2
260
692.13M
98.13%
+14.08M
2024Q1
228
669.32M
95.38%
+36.91M
2023Q4
210
620.08M
88.82%
-5.65M
2023Q3
205
616.45M
88.38%
+11.96M
2023Q2
199
619.05M
88.77%
+407.10M
2023Q1
178
604.96M
86.79%
+406.66M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Duggan (Robert William)
555.75M
74.83%
+74.55K
+0.01%
May 30, 2025
Zanganeh (Mahkam)
35.74M
4.81%
+359.73K
+1.02%
Apr 15, 2025
Baker Bros. Advisors LP
24.42M
3.29%
--
--
Mar 31, 2025
Xia (Yu)
31.52M
4.24%
--
--
Apr 15, 2025
Fidelity Management & Research Company LLC
9.31M
1.25%
+1.29M
+16.12%
Mar 31, 2025
The Vanguard Group, Inc.
11.64M
1.57%
-30.07K
-0.26%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
7.51M
1.01%
-43.09K
-0.57%
Mar 31, 2025
State Street Global Advisors (US)
4.85M
0.65%
-751.52K
-13.41%
Mar 31, 2025
T. Rowe Price Associates, Inc.
6.46M
0.87%
-11.97K
-0.19%
Mar 31, 2025
Soni (Manmeet Singh)
3.02M
0.41%
--
--
Apr 15, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
Tema Oncology ETF
2.83%
ProShares Ultra Nasdaq Biotechnology
1.76%
Invesco Nasdaq Biotechnology ETF
1.76%
SPDR S&P Biotech ETF
1.07%
Invesco NASDAQ Next Gen 100 ETF
0.96%
Virtus LifeSci Biotech Clinical Trials ETF
0.95%
Invesco ESG NASDAQ Next Gen 100 ETF
0.71%
Direxion Daily S&P Biotech Bull 3X Shares
0.61%
iShares Biotechnology ETF
0.25%
Goldman Sachs Equal Weight US Large Cap Equity ETF
0.21%
查看更多
Tema Oncology ETF
佔比2.83%
ProShares Ultra Nasdaq Biotechnology
佔比1.76%
Invesco Nasdaq Biotechnology ETF
佔比1.76%
SPDR S&P Biotech ETF
佔比1.07%
Invesco NASDAQ Next Gen 100 ETF
佔比0.96%
Virtus LifeSci Biotech Clinical Trials ETF
佔比0.95%
Invesco ESG NASDAQ Next Gen 100 ETF
佔比0.71%
Direxion Daily S&P Biotech Bull 3X Shares
佔比0.61%
iShares Biotechnology ETF
佔比0.25%
Goldman Sachs Equal Weight US Large Cap Equity ETF
佔比0.21%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
